Highlights include Expanded Global Patent Portfolio, Complete Debt Elimination Strengthening Balance...
News Room
Patents strengthen Envoy Medical's innovation pipeline and protect next-generation cochlear implant ...
No Serious Adverse Events or Unanticipated Device Effects Reported; Company Confirms Program Remains...
Extinguishment simplifies capital structure, strengthens foundation for growth, and eliminates all t...
Patents issued in the U.S., Australia, and Hong Kong advance Envoy Medical's innovation pipeline and...
White Bear Lake, Minnesota--(Newsfile Corp. - July 31, 2025) - Envoy Medical ® , Inc. (NASDAQ: COCH)...
White Bear Lake, Minnesota--(Newsfile Corp. - July 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("E...
White Bear Lake, Minnesota--(Newsfile Corp. - July 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("E...
The Esteem(R) device by Envoy Medical is the only totally implantable active middle ear implant with...
Positive momentum from the trial's first stage encouraging Company to accelerate plans for expansion...
*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.
Be the first to know!
Subscribe to news updates.
